[1] THANIKACHALAM K, KHAN G. Colorectal cancer and nutrition[J]. Nutrients, 2019, 11(1):164. [2] DEKKER E, TANIS P J, VLEUGELS J L A, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207):1467-1480. [3] WANG L Y, CHO K B, LI Y, et al. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer[J]. Int J Mol Sci, 2019, 20(22):5758. [4] BHAN A, SOLEIMANI M, MANDAL S S. Long noncoding RNA and cancer:a new paradigm[J]. Cancer Res, 2017, 77(15):3965-3981. [5] MCCABE E M, RASMUSSEN T P. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions[J]. Semin Cancer Biol, 2021, 75:38-48. [6] CHAN J J, TAY Y. Noncoding RNA:RNA regulatory networks in cancer[J]. Int J Mol Sci, 2018, 19(5):1310. [7] SHI J X, ZHONG X, SONG Y X, et al. Long non-coding RNA RUNX1-IT1 plays a tumour-suppressive role in colorectal cancer by inhibiting cell proliferation and migration[J]. Cell Biochem Funct, 2019, 37(1):11-20. [8] BAIDOUN F, ELSHIWY K, ELKERAIE Y, et al. Colorectal cancer epidemiology:recent trends and impact on outcomes[J]. Curr Drug Targets, 2021, 22(9):998-1009. [9] SIEGEL R L, JAKUBOWSKI C D, FEDEWA S A, et al. Colorectal cancer in the young:epidemiology, prevention, management[J]. Am Soc Clin Oncol Educ Book, 2020, 40((4)):1-14. [10] LA VECCHIA S, SEBASTIÁN C. Metabolic pathways regulating colorectal cancer initiation and progression[J]. Semin Cell Dev Biol, 2020, 98:63-70. [11] SINHA R. Colorectal cancer[J]. Clin Radiol, 2021, 76(12):870. [12] CHI, WANG, WANG, et al. Long non-coding RNA in the pathogenesis of cancers[J]. Cells, 2019, 8(9):1015. [13] REGGIARDO R E, MAROLI S V, KIM D H. LncRNA biomarkers of inflammation and cancer[J]. Adv Exp Med Biol, 2022, 1363:121-145. [14] HUANG F J, LIU Y L, WANG J, et al. LncRNA RUNX1-IT1 affects the differentiation of Th1 cells by regulating NrCAM transcription in Graves' disease[J]. Cell Cycle, 2022, 21(9):921-933. [15] LIANG M L, WANG H B, LIU C, et al. LncRNA RUNX1-IT1 is downregulated in endometrial cancer and binds to miR-21 precursor to suppress its maturation[J]. Cancer Manag Res, 2020, 12:13451-13459. [16] MIAO Y J, LI T, LIU Y F, et al. The molecular mechanism of long non-coding ribonucleic acid (lncRNA) RUNX1-IT1 promotes the proliferation and stemness of lung cancer cells[J]. Transl Cancer Res, 2021, 10(11):4884-4893. [17] SUN L K, WANG L, CHEN T X, et al. LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells[J].Cell Death Dis, 2020, 11(2):1-15. [18] YAN P H, WANG L, CHEN H, et al. LncRNA RUNX1-IT1 inhibits proliferation and promotes apoptosis of hepatocellular carcinoma by regulating MAPK pathways[J]. Eur Rev Med Pharmacol Sci, 2019, 23(19):8287-8294. [19] WU Z. miR-195 connects lncRNA RUNX1-IT1 and cyclin D1 to regulate the proliferation of glioblastoma cells[J]. Int J Neurosci, 2021:1-6. [20] SINGH A, SINGH A K, GIRI R, et al. The role of microRNA-21 in the onset and progression of cancer[J]. Future Med Chem, 2021, 13(21):1885-1906. [21] ZHANG Z, WANG J M, WANG X F, et al. microRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3[J]. Arch Gynecol Obstet, 2018, 297(2):433-442. [22] REN J, KUANG T H, CHEN J, et al. The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer:a meta-analysis[J]. Eur Rev Med Pharmacol Sci, 2017, 21(1):120-130. [23] CRETOIU D. miR-21 regulates growth and EMT in lung cancer cells via PTEN Akt GSK3 beta signaling[J]. Front Biosci, 2019, 24(8):1426-1439. |